Copyright
©The Author(s) 2025.
World J Gastroenterol. Feb 7, 2025; 31(5): 102249
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102249
Published online Feb 7, 2025. doi: 10.3748/wjg.v31.i5.102249
Figure 1 Flow chart depicting the screening of gastric cancer patients who received sintilimab combined with chemotherapy.
PD-1: Programmed cell death protein 1; PD-L1: Programmed cell death ligand 1; TyG: Triglyceride glucose.
- Citation: Yao ZY, Ma X, Cui YZ, Liu J, Han ZX, Song J. Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy. World J Gastroenterol 2025; 31(5): 102249
- URL: https://www.wjgnet.com/1007-9327/full/v31/i5/102249.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i5.102249